Next Article in Journal
Lysophosphatidylethanolamine Affects Lipid Accumulation and Metabolism in a Human Liver-Derived Cell Line
Previous Article in Journal
Distinct Roles of Distress and Coping Capacity in the Effects of Psychological Stress on Energy Intake and Percentage of Energy from Macronutrients
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Mediation Role of the Risk of Non-Alcoholic Fatty Liver Disease in Relationship between Lutein and Zeaxanthin and Cognitive Functions among Older Adults in the United States

Department of Epidemiology and Health Statistics, School of Public Health, Qingdao University, No. 308, Ningxia Road, Qingdao 266021, China
*
Author to whom correspondence should be addressed.
Nutrients 2022, 14(3), 578; https://doi.org/10.3390/nu14030578
Submission received: 4 December 2021 / Revised: 25 January 2022 / Accepted: 26 January 2022 / Published: 28 January 2022
(This article belongs to the Section Nutrition and Public Health)

Abstract

:
Background: Previous studies showed lutein and zeaxanthin (L and Z) may influence cognitive function by different mechanisms. Our study aimed to be the first to examine whether the risk of non-alcoholic fatty liver disease (NAFLD) mediated the possible association between the dietary intake of L and Z and cognitive function. Methods: We conducted a cross-sectional analysis of participants aged 60 years or over in the National Health and Nutrition Examination Survey (NHANES) 2011–2014. Multivariable linear regression was used to investigate the association between the dietary intake of L and Z and cognitive function, and structural equation modeling tested the mediation effect. Results: The fatty liver index for the United States population (US FLI) acted as a mediator in the association between the higher intake of L and Z and the Animal Fluency Test, the Digit Symbol Substitution Test (DSST), and composite score and mediated 13.89%, 17.87%, and 13.79% of the total association in dietary L and Z intake (14.29%, 13.68%, and 10.34% of the total association in total L and Z intake), respectively. Conclusion: Our study indicated the potential role of the risk of NAFLD as a mediator of associations between the dietary intake of L and Z and cognitive function in the geriatric American population.

1. Introduction

With the increase in the number of older population members worldwide, the health problems of older adults are becoming increasingly serious. In particular, aging may lead to age-related cognitive impairment. Owing to vascular risk factors, cardiovascular health declines with age, and this causes an increase in the risk of cognitive impairment [1]. Mild cognitive impairment (MCI) is known as the negative and pathological cognitive changes beyond what is expected in normal aging and is a potential transitional process between normal aging and dementia (mainly Alzheimer’s disease (AD)) [1]. Cognitive impairment continues to worsen without any prevention or intervention and develops into pathological MCI and even dementia [2]. Previous study showed that an estimated 35.6 million people worldwide had dementia in 2010, compared with an estimated 65.7 million in 2030 and 115.4 million in 2050 [3]. Cognitive health has become an important public health issue affecting the aging population all over the world. The progression of cognitive impairment to AD is irreversible, and there are numerous cases of treatment failure. There is currently no cure for AD, so it is necessary to identify changeable factors that affect cognitive function and to intervene before older adults develop AD.
A cohort study indicated that dietary antioxidant deficiency is a modifiable risk factor for cognitive decline [4]. Carotenoids are dietary antioxidants; lutein and zeaxanthin (L and Z hereafter) are 2 of 600 natural carotenoids, and they must be obtained by diet, mainly through the intake of green leafy vegetables and varieties of fruits [5]. L and Z are, structurally, isomers of each other, and it is difficult to distinguish L and Z. Previous studies have always reported them as a class of substances, the most notable feature of which being that they preferentially accumulate in the macula of the eye [6] and brain [7], including frontal, occipital, and temporal cortices, cerebellum, and pons. Above all, their levels in the brain account for 66–77% of the total brain carotenoid levels [5]. In previous literature involving United States (US) older samples, L and Z were positively correlated with multiple measures of cognitive functions [8,9,10]. Although some studies have shown that L and Z may influence cognition through anti-inflammatory and antioxidant properties, the underlying mechanisms are not clear. Moreover, the analysis of the mediation between L and Z, and cognition is also limited. To sum up, it is necessary to explore the mechanism between L and Z and human cognitive functions.
The anti-inflammatory and antioxidant capacities of L and Z may also affect the inflammatory development of non-alcoholic fatty liver disease (NAFLD) [11] and may also hinder the metabolism of lipids, thus aggravating fatty liver disease. NAFLD is the most common type of chronic liver disease in the US, and its incidence is on the rise globally [12]. Epidemiological studies and laboratory animal studies have found significant associations between a higher carotenoid intake (including L and Z) and a lower risk of NAFLD [13,14,15]. Existing evidence has shown that treatment with lutein lowers the levels of inflammatory genes in the body [16].
Moreover, complications of NAFLD have been reported to include cognitive impairment [17,18]. Up to 70% of NAFLD cases are associated with a negative effect on cognitive problems, such as memory and attention [19]. NAFLD was recently identified as metabolic-associated fatty liver disease (MAFLD) [20] and as an independent risk factor acting on vascular dysfunction and cognitive-related disorders [18]. Therefore, we speculate that the risk of NAFLD may have a mediating effect between L and Z intake and cognitive functions.
No previous study has directly explored whether the risk of NAFLD mediates dietary L and Z intake and cognitive functions in older adults. Therefore, we explored the mediation role of the risk of NAFLD and explain the details of the pathway. The objective of our study was to investigate the existence of mediating effects, with the possibility that the risk of NAFLD could be an important intervention target to intervene upon with the decline in cognition in older adults.

2. Materials and Methods

2.1. Study Design

The National Health and Nutrition Examination Survey (NHANES) is a cross-sectional survey designed to provide a representative sample of the US non-institutionalized civilian population [21]. The National Center for Health Statistics Ethics Review Board of Centers for Disease Control (CDC) sanctioned all NHANES projects and every participant signed their informed consent.
Two cycles (2011/2012 and 2013/2014) included the collected information via cognitive function tests. A total of 19,931 participants took part in the 2011–2014 NHANES. Among the participants aged 60 years or over (n = 3632), we excluded participants based on the following criteria: missing information about the fatty liver index for the US population (US FLI), cognitive tests, L and Z dietary intake, and covariates (n = 2423); individuals characterized by the production of hepatitis B or C antibody (n = 128); and missing information about alcohol intake or excessive alcohol drinking (1 drink/day for women or 2 drinks/day for men) (n = 453). The participants who had other self-reported liver diseases (n = 24) were also excluded to avoid the confounding effects. Finally, 604 participants (weighted n =29,397,912) were included in the analysis.

2.2. Lutein and Zeaxanthin in Dietary and Total Intake

In total, 2 sets of 24 h dietary information were obtained via interviews in the 2 cycles; they were used to assess the participants’ dietary nutrients and energy intake during these periods. The interviews were conducted in a private room in the Mobile Examination Center (MEC), containing a standard set of measuring guides. The first dietary recall was collected in-person during the NHANES visit, while the second was collected over telephone 3–10 days later. After the first dietary recall interview, the participants were given measuring cups, spoons, a ruler, and two-dimensional drawings of the various measuring guides available in the MEC, to use for reporting food amounts during the telephone interview [22]. The total estimated dietary L and Z intake was averaged over the two recall periods (if only the first day was available, that value was used instead of the average). The total energy intake was also acquired during the 24 h dietary recall. The participants were queried about supplement use for the same two 24 h periods; L and Z intake from supplements was also averaged over two days if available. The total L and Z intake was calculated as the sum of dietary and supplement intake.

2.3. NAFLD—Related Measurement

Patients with NAFLD present with excessive deposition of fat in the liver, different from other liver diseases due to other causes and too much alcohol intake. The prediction of the risk of NAFLD was based upon the US FLI [23,24,25]. The fatty liver index (FLI) was first found from a study in north-central Italy. Then, the US FLI was derived for the multi-ethnic US NHANES and was used in healthy people to estimate the risk of NAFLD [24]. The specific formula is as follows.
US   FLI = ( e 0.8073 × non Hispanicblack + 0.3458 × MexicanAmerican + 0.0093 × age + 0.6151 × log e ( GGT ) + 0.0249 × waistcircumference + 1.1792 × log e ( insulin ) + 0.8242 × log e ( glucose ) 14.7812 ) /   ( 1 + e 0.8073 × non Hispanicblack + 0.3458 × MexicanAmerican + 0.0093 × age + 0.6151 × log e ( GGT ) + 0.0249 × waistcircumference + 1.1792 × log e ( insulin ) + 0.8242 × log e ( glucose ) 14.7812 ) × 100 .
The US FLI ranges from 0 to 100 [24]. In our analyses, we used the US FLI as a continuity variable to explore the importance of early dietary prevention of NAFLD on cognitive functions.

2.4. Cognitive Outcomes

In the cycles of NHANES (2011–2014), cognitive function tests were carried out at the MEC for participants aged 60 years or older [26,27]. Three tests were included—namely, the Consortium to Establish a Registry for AD Word Learning subtest (CERAD W-L), the Animal Fluency Test, and the Digit-Symbol Substitution Test (DSST). The CERAD W-L executed the task of immediate and delayed recall of new verbal information consisting of three consecutive learning trials, as well as a delayed recall. For each test, the participants were asked to read 10 words and then recall as many learned words as they could immediately and after a few minutes. In the end, the results were calculated by the number of right answers as three individual trial scores ranging from 0 to 10, a total score among all three trials ranging from 0 to 30, and one delayed recall score ranging from 0 to 10. The Animal Fluency Test was used to evaluate categorical verbal fluency (a vital component of executive functions). Participants were instructed to list as many animal names as they could in one minute and obtained one point when a correct answer was given. Although there was no upper limit, the total score ranged from 3 to 36 in our analysis. The DSST, a module of the Wechsler Adult Intelligence Test, was used to evaluate processing speed, sustained attention, and working memory, and its score ranged from 2 to 105 in our analysis. Each participant was provided a piece of paper and was required to match the right symbols in 133 boxes with numbers in 2 min and connect them. The total score was the number of correct matches. Then, the Z-score was calculated from the average of the total standardized scores on the three cognitive tests to estimate the overall score level.

2.5. Statistical Analysis

All statistical analyses were adjusted for the survey design and the weighting of the variables to illustrate the complex sampling design, making sure of national representation. Fasting information in this study was collected from those sample participants who were subsampled to fast before attending Mobile Examination Center (MEC) exams. Due to the smallest subpopulation being in the fasting group, we used the fasting subsample weights (wtsaf4yr). Because of the two cycles included, we created four-year new weights as one-half of the value of the fasting sub-sample MEC weight (WTSAF2YR×1/2) included in all analyses, according to the analytical guidelines of the NHANES [28]. The characteristics across the different groups are presented as mean ± standard error (SE) for continuous variables and as proportion (SE) for categorical variables. The US FLI and cognitive function tests were compared among different L and Z groups using a one-way analysis of variance (ANOVA). To examine the relation of L and Z intake to US FLI and cognitive function scores, L and Z intake was divided into four groups according to the quartiles based on frequency distributions (quartiles (Q) of L and Z intake; L and Z dietary intake ranged from 0 to 532 mcg, from 532.5 to 900 mcg, from 901.5 to 1801.5 mcg, and from 1816.5 to 146911.5 mcg in Q1, Q2, Q3, and Q4, respectively. Moreover, L and Z total intake ranged from 0 to 569.5 mcg, from 578.5 to 1011 mcg, from 1022.5 to 2055 mcg, and from 2076.5 to 161911.5 mcg in Q1, Q2, Q3, and Q4, respectively). The correlations among cognitive composite scores, US FLI, and dietary or total L and Z intake were investigated by conducting multiple linear regressions. Mediation analyses were used to investigate whether the US FLI significantly influenced the relationship between the L and Z groups (Q2 vs. Q1, Q3 vs. Q1, and Q4 vs. Q1) and cognitive function tests. Then, we transformed four categories of L and Z intake into three dummy codes and tested the mediation by structural equation modeling (SEM), as suggested by Hayes and Preacher (2014), combining bootstrapping sampling methods and bias-corrected bootstrap confidence intervals [29]. The relative direct effect and indirect effect of groups across US FLIs were analyzed. Age, gender, race/ethnicity, educational level, total energy intake, and the survey year of the participants were included as covariates. All the statistical analyses were conducted using Stata SE 15.0 (Stata Corp LP, College Station, TX, USA). A p-value < 0.05 was used to define statistical significance, and all tests were two-sided.

3. Results

3.1. General Characteristics

Table 1 shows the basic characteristics’ comparison between the two NHANES cycles’ participants aged 60 years or over and the participants involved in our analysis. We included 604 participants in our study and carried out the weighted process (weighted n = 29, 397, 912). When classified by NHANES cycles and sex, the participants’ distribution was relatively even, just as was found by previous research studies in the same area [30]. The mean age of the participants was about 68–70 years. In terms of racial proportion, the majority self-reported as non-Hispanic white (about 87%), followed by non-Hispanic Black (around 5%). Moreover, there were approximately 88% participants having undergone education for more than 12 years. The mean value of the components involved in the US FLI and the scores of the three cognitive tests were generally higher in the analyzed group. The three cognitive function tests, Z-score, and US FLI were all associated with dietary and total L and Z intake (Table 2). The differences among the four cognitive indexes and the US FLI in the four groups of L and Z intake were statistically significant.

3.2. Association of Dietary L and Z Intake with Cognitive Functions

In Table 3, the comparisons between the crude model and adjusted model show the change in and 95% confidence interval of the cognitive function scores with the per-quartile increase in dietary or total L and Z intake. After adjusting for confounders, no matter the dietary or total intake, the Q4 group of L and Z was positively associated with three cognitive function scores and Z-score compared with the first group. In the model of total intake of L and Z, both the Q3 and Q4 groups of L and Z showed significant associations, suggesting increased intake of L and Z may be relevant to higher cognitive test scores or satisfactory performance.

3.3. Association of the US FLI with Cognitive Functions

As Table 3 shows, the association between the US FLI and cognitive functions was statistically significant. In the adjusted model, a lower US FLI was related to higher cognition test scores and Z-score, with the β(95% CI) being −0.03 (−0.06, −0.01), −0.09 (−0.16, −001), and −0.004 (−0.01, −0.00) for the Animal Fluency Test, DSST, and Z-score, respectively.

3.4. Association of Dietary L and Z Intake with US FLI

Table 4 shows us that a higher L and Z intake may correlate with a lower US FLI. The Q4 group of dietary L and Z intake, compared with the control group, was negatively associated with the US FLI (β= −10.23); the results of the Q4 group of L and Z total intake results were similar to the results of L and Z dietary intake (β= −9.84) after adjusting the confounding factors.

3.5. Mediation Effects of the US FLI on Relationship between Dietary or Total L and Z Intake and Cognitive Functions

Figure 1 provides a path model that indicates the mediation effect of the US FLI. In Table 5 and Table 6, for the relative mediation effect analysis, the results of the bootstrapping show that the US FLI had a significant relative indirect effect on both the dietary and total L and Z intake Q4 group and Animal Fluency Test score (indirect effect (an × b): 0.30), DSST score (indirect effect (an × b): 0.84), and Z-score (indirect effect (an × b): 0.04). The results of the bootstrapping also show that the US FLI had a significant relative indirect effect on the total L and Z intake Q4 group and the Animal Fluency Test score (indirect effect (anvb): 0.30), DSST score (indirect effect (an × b): 0.78), and Z-score (indirect effect (an×b): 0.03). Compared with the dietary control group (Q1), the Q4 group had increased Animal Fluency Test score, DSST score, and Z-score by 0.30, 0.84, and 0.04 units, respectively. Compared with the total intake control group (Q1), the Q4 group had increased Animal Fluency Test score, DSST score, and Z-score by 0.30, 0.78, and 0.03 units, respectively. In Table 6, we can see that the direct effects of the total L and Z intake Q4 group on the four cognitive function scores were all significant. All the results above indicate that the US FLI mediated the relationship between higher L and Z intake and cognitive functions. As for the mediation analysis from the bias-corrected bootstrap, the proportion of the US FLI explaining the dietary L and Z intake Q4 group was 13.89% for the Animal Fluency Test, 17.87% for the DSST, and 13.79% for the Z-score. The proportion of the US FLI explaining the total L and Z intake Q4 group was 14.29% for the Animal Fluency Test, 13.68% for the DSST, and 10.34% for the Z-score. Higher L and Z intake may be indirectly related to better cognitive performance among the factors of reduced risk of NAFLD.

4. Discussion

This cross-sectional study used two NHANES cycles (2011–2012 and 2013–2014) and explored whether the risk of NAFLD mediated the relationship between dietary L and Z intake and cognitive functions in older adults in the US. The link between the risk of NAFLD and cognitive functions was analyzed in the continuous NHANES database for the first time.

4.1. Association between Dietary L and Z Intake with Cognitive Functions

The higher the L and Z intake was, the better cognitive performance in the memory, language, and executive function fields was. The results of this study are broadly consistent with those of previous studies in populations at risk of NAFLD [5,30,31,32,33,34]. After adjusting for potential confounders, we found that the relationships between dietary L and Z intake and three cognitive tests’ scores remained statistically significant. Studies have shown that a moderate intake of L and Z is a sign of a healthy lifestyle and may reduce oxidation or inflammation and maintain meningeal stability [33,35]. Additionally, L and Z accumulate in the membranes of brain tissues and have protective effects on the axons, which play a significant role in the structural and functional integrity of the membranes of brain cells [36]. Similarly, cognitive impairment is associated with brain tissue damage, dysfunction, cell death, and cell and nerve junction damage. Such evidence provides an important basis for the study of the relationship between dietary L and Z intake and cognitive functions.

4.2. Dietary L and Z Intake, NAFLD and Cognitive Functions

This analysis used the US FLI to assess the risk of NAFLD. The US FLI is a simple, non-invasive scoring system measuring the risk of fatty liver in people in the US. Our study found that dietary and total L and Z intake were related to the US FLI and so were the relationships between the US FLI and three cognitive tests (including Z-scores).
A study of US adults showed that the higher levels of L and Z carotenoid intake may reduce the risk of NAFLD [37] and inhibit the progression of simple hepatic steatosis to nonalcoholic steatohepatitis (NASH) by reducing oxidative stress responses in the liver and pro-inflammatory cytokines secreted by liver macrophages, as well as by reducing immune infiltration and insulin sensitivity [11]. Furthermore, animal studies have supported that carotenoid (including lutein) administration may impede the accumulation of lipids in the liver with the consumption of a high-fat diet [15], increasing the expression of SIRT1, a key gene regulator for fatty acid oxidation. Kim’s animal tests on guinea pigs showed that lutein supplementation could lower the factor levels in guinea pigs on a high-cholesterol diet by reducing the DNA binding activity of NF-κB [38]. Qiu’s experiment found that lutein supplementation reduced the hepatic TC and TG levels in hyperlipidemia rats and increased the levels of PPAR-αprotein, thereby enhancing the oxidation of fatty acids [15,39]. In addition, the US FLI was found to be higher in people with lower L and Z intake, indicating a greater risk of NAFLD. In summary, carotenoids may influence hepatic disease status by disturbing lipid metabolism. On the other hand, a review has shown that NAFLD is a multi-system disease that may influence cognition through systemic and neuro-inflammation, metabolic liver dysfunction and ammonia metabolism disorder, disturbed gut microbiota, atherosclerosis and cerebrovascular dysfunction, neurodegeneration, and obstructive sleep apnea [40].
The above mechanisms provide evidence of the existence of the mediation effects. The finding indicating that the risk of NAFLD mediated the association between L and Z and cognitive functions further underscores the crucial role of the risk of NAFLD in the development of cognitive impairment in individuals under L and Z intake treatment. Thus, the results further provide the recommendation for the risk assessment of NAFLD and early L and Z supplementation to reduce the detrimental effects of cognitive impairment.

4.3. Study Strengths and Limitations

There are several strengths in our study. First, the main strength is the use of the NHANES survey, which is of high quality due to the survey methods and quality control. Second, the validity of the results is explained by the fact that the mediating effect of the US FLI still existed after adjusting for major confounders. Third, our study is the first to test the relationship between cognition and the US FLI in the continuous NHANES database. Fourth, to estimate the risk of NAFLD, our study used the US FLI—a better, non-invasive system index, compared to an invasive liver biopsy. Additionally, the use of SEM for the mediation analysis of multiple classification-independent variables also has advantages: the measurement error could be effectively controlled to obtain a more accurate mediation effect value [29], and the bootstrap method was integrated into the analysis of SEM.
There are also some limitations in our study. First, this was a cross-sectional study. Further prospective studies are needed to collect more unmeasured confounders to verify the mediating effect. Second, the supplement information for dietary L and Z intake was partially missing, and there may have been recall bias. In addition, future studies are necessary to evaluate the value of the US FLI to explore the role of NAFLD in brain health. It may have significant research prospects.

5. Conclusions

Our results suggest that the risk of NAFLD might play a mediation role between higher dietary intake of L and Z, and cognitive functions, compared with the lowest intake, and that the risk of NAFLD may be an important intervention target in older adults. Therefore, early improvement in L and Z intake would be necessary to protect cognition by reducing the risk of NAFLD. More prospective studies and larger populations are needed to continue to verify the existence of the mediation effect and explore more pathways.

Author Contributions

C.C., Z.L. and S.L. conceived and designed the study; C.C., Z.L. and S.L. analyzed the data and wrote the draft; D.Z. revised the manuscript; S.L. reviewed the manuscript and had primary responsibility for the final content. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by National Natural Science Foundation of China 82003535 and China Postdoctoral Science Foundation General Project 2018M630758.

Institutional Review Board Statement

Ethical review and approval were waived for this study since all the data from National Health and Nutrition Examination Survey are publicly accessible.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data are available at https://www.cdc.gov/nchs/nhanes/index.htm (accessed date: 3 December 2021).

Acknowledgments

We acknowledge the National Center for Health Statistics at the CDC, who design, collect, and administer the NHANES data and make the data available for public use.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Tsentidou, G.; Moraitou, D.; Tsolaki, M. Cognition in Vascular Aging and Mild Cognitive Impairment. J. Alzheimers Dis. 2019, 72, 55–70. [Google Scholar] [CrossRef] [PubMed]
  2. Li, S.; Sun, W.; Zhang, D. Association of Zinc, Iron, Copper, and Selenium Intakes with Low Cognitive Performance in Older Adults: A Cross-Sectional Study from National Health and Nutrition Examination Survey (NHANES). J. Alzheimers Dis. 2019, 72, 1145–1157. [Google Scholar] [CrossRef] [PubMed]
  3. Prince, M.; Bryce, R.; Albanese, E.; Wimo, A.; Ribeiro, W.; Ferri, C.P. The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement. 2013, 9, 63–75. [Google Scholar] [CrossRef] [PubMed]
  4. Nooyens, A.C.; Milder, I.E.; van Gelder, B.M.; Bueno-de-Mesquita, H.B.; van Boxtel, M.P.; Verschuren, W.M. Diet and cognitive decline at middle age: The role of antioxidants. Br. J. Nutr. 2015, 113, 1410–1417. [Google Scholar] [CrossRef] [Green Version]
  5. Lindbergh, C.A.; Mewborn, C.M.; Hammond, B.R.; Renzi-Hammond, L.M.; Curran-Celentano, J.M.; Miller, L.S. Relationship of Lutein and Zeaxanthin Levels to Neurocognitive Functioning: An fMRI Study of Older Adults. J. Int. Neuropsychol. Soc. 2017, 23, 11–22. [Google Scholar] [CrossRef] [Green Version]
  6. Renzi, L.M.; Hammond, B.R., Jr. The relation between the macular carotenoids, lutein and zeaxanthin, and temporal vision. Ophthal. Physiol. Opt. 2010, 30, 351–357. [Google Scholar] [CrossRef]
  7. Johnson, E.J.; Vishwanathan, R.; Johnson, M.A.; Hausman, D.B.; Davey, A.; Scott, T.M.; Green, R.C.; Miller, L.S.; Gearing, M.; Woodard, J.; et al. Relationship between Serum and Brain Carotenoids, alpha-Tocopherol, and Retinol Concentrations and Cognitive Performance in the Oldest Old from the Georgia Centenarian Study. J. Aging Res. 2013, 2013, 951786. [Google Scholar] [CrossRef] [Green Version]
  8. Kesse-Guyot, E.; Ahluwalia, N.; Lassale, C.; Hercberg, S.; Fezeu, L.; Lairon, D. Adherence to Mediterranean diet reduces the risk of metabolic syndrome: A 6-year prospective study. Nutr. Metab. Cardiovasc. Dis. 2013, 23, 677–683. [Google Scholar] [CrossRef]
  9. Kang, J.H.; Ascherio, A.; Grodstein, F. Fruit and vegetable consumption and cognitive decline in aging women. Ann. Neurol. 2005, 57, 713–720. [Google Scholar] [CrossRef]
  10. Parrott, M.D.; Shatenstein, B.; Ferland, G.; Payette, H.; Morais, J.A.; Belleville, S.; Kergoat, M.J.; Gaudreau, P.; Greenwood, C.E. Relationship between diet quality and cognition depends on socioeconomic position in healthy older adults. J. Nutr. 2013, 143, 1767–1773. [Google Scholar] [CrossRef]
  11. Murillo, A.G.; DiMarco, D.M.; Fernandez, M.L. The Potential of Non-Provitamin a Carotenoids for the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease. Biology 2016, 5, 42. [Google Scholar] [CrossRef] [PubMed]
  12. Lee, J.W.; Park, S.H. Association between depression and nonalcoholic fatty liver disease: Contributions of insulin resistance and inflammation. J. Affect. Disord 2021, 278, 259–263. [Google Scholar] [CrossRef] [PubMed]
  13. Clugston, R.D. Carotenoids and fatty liver disease: Current knowledge and research gaps. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids 2020, 1865, 158597. [Google Scholar] [CrossRef] [PubMed]
  14. Kim, J.H.; Na, H.J.; Kim, C.K.; Kim, J.Y.; Ha, K.S.; Lee, H.; Chung, H.T.; Kwon, H.J.; Kwon, Y.G.; Kim, Y.M. The non-provitamin A carotenoid, lutein, inhibits NF-kappaB-dependent gene expression through redox-based regulation of the phosphatidylinositol 3-kinase/PTEN/Akt and NF-kappaB-inducing kinase pathways: Role of H(2)O(2) in NF-kappaB activation. Free Radic. Biol. Med. 2008, 45, 885–896. [Google Scholar] [CrossRef] [PubMed]
  15. Qiu, X.; Gao, D.H.; Xiang, X.; Xiong, Y.F.; Zhu, T.S.; Liu, L.G.; Sun, X.F.; Hao, L.P. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats. World J. Gastroenterol. 2015, 21, 8061–8072. [Google Scholar] [CrossRef] [PubMed]
  16. Christensen, K.; Lawler, T.; Mares, J. Dietary Carotenoids and Non-Alcoholic Fatty Liver Disease among US Adults, NHANES 2003–2014. Nutrients 2019, 11, 1101. [Google Scholar] [CrossRef] [Green Version]
  17. Colognesi, M.; Gabbia, D.; De Martin, S. Depression and Cognitive Impairment-Extrahepatic Manifestations of NAFLD and NASH. Biomedicines 2020, 8, 229. [Google Scholar] [CrossRef]
  18. Lombardi, R.; Fargion, S.; Fracanzani, A.L. Brain involvement in non-alcoholic fatty liver disease (NAFLD): A systematic review. Dig. Liver Dis. 2019, 51, 1214–1222. [Google Scholar] [CrossRef]
  19. Elliott, C.; Frith, J.; Day, C.P.; Jones, D.E.; Newton, J.L. Functional impairment in alcoholic liver disease and non-alcoholic fatty liver disease is significant and persists over 3 years of follow-up. Dig. Dis. Sci. 2013, 58, 2383–2391. [Google Scholar] [CrossRef]
  20. Eslam, M.; Sanyal, A.J.; George, J. International Consensus P: MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology 2020, 158, 1999–2014. [Google Scholar] [CrossRef]
  21. NHANES Questionnaires, Datasets, and Related Documentation. Available online: https://wwwn.cdc.gov/nchs/nhanes/default.aspx (accessed on 3 December 2021).
  22. National Health and Nutrition Examination Survey Measuring Guides for the Dietary Recall Interview. Available online: https://www.cdc.gov/nchs/nhanes/measuring_guides_dri/measuringguides.htm (accessed on 3 December 2021).
  23. Calori, G.; Lattuada, G.; Ragogna, F.; Garancini, M.P.; Crosignani, P.; Villa, M.; Bosi, E.; Ruotolo, G.; Piemonti, L.; Perseghin, G. Fatty liver index and mortality: The Cremona study in the 15th year of follow-up. Hepatology 2011, 54, 145–152. [Google Scholar] [CrossRef] [PubMed]
  24. Ruhl, C.E.; Everhart, J.E. Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey. Aliment. Pharmacol. Ther. 2015, 41, 65–76. [Google Scholar] [CrossRef] [PubMed]
  25. Lerchbaum, E.; Pilz, S.; Grammar, T.B.; Boehm, B.O.; Stojakovic, T.; Obermayer-Pietsch, B.; Marz, W. The fatty liver index is associated with increased mortality in subjects referred to coronary angiography. Nutr. Metab. Cardiovasc. Dis. 2013, 23, 1231–1238. [Google Scholar] [CrossRef] [PubMed]
  26. National Health and Nutrition Examination Survey 2011–2012 Data Documentation, codebook and Frequencies. Cognitive Functioning. Available online: https://wwwn.cdc.gov/Nchs/Nhanes/2011-2012/CFQ_G.htm (accessed on 3 December 2021).
  27. National Health and Nutrition Examination Survey 2013–2014 Data Documentation, codebook and Frequencies. Cognitive Functioning. Available online: https://wwwn.cdc.gov/Nchs/Nhanes/2013-2014/CFQ_H.htm (accessed on 3 December 2021).
  28. National Health and Nutrition Examination Survey. NHANES Tutorials—Module 3—Weighting. Available online: https://wwwn.cdc.gov/nchs/nhanes/tutorials/module3.aspx (accessed on 3 December 2021).
  29. Hayes, A.F.; Preacher, K.J. Statistical mediation analysis with a multicategorical independent variable. Br. J. Math. Stat. Psychol. 2014, 67, 451–470. [Google Scholar] [CrossRef] [PubMed]
  30. Christensen, K.; Gleason, C.E.; Mares, J.A. Dietary carotenoids and cognitive function among US adults, NHANES 2011–2014. Nutr. Neurosci. 2020, 23, 554–562. [Google Scholar] [CrossRef]
  31. Hammond, B.R., Jr.; Miller, L.S.; Bello, M.O.; Lindbergh, C.A.; Mewborn, C.; Renzi-Hammond, L.M. Effects of Lutein/Zeaxanthin Supplementation on the Cognitive Function of Community Dwelling Older Adults: A Randomized, Double-Masked, Placebo-Controlled Trial. Front. Aging Neurosci. 2017, 9, 254. [Google Scholar] [CrossRef]
  32. Lindbergh, C.A.; Renzi-Hammond, L.M.; Hammond, B.R.; Terry, D.P.; Mewborn, C.M.; Puente, A.N.; Miller, L.S. Lutein and Zeaxanthin Influence Brain Function in Older Adults: A Randomized Controlled Trial. J. Int. Neuropsychol. Soc. 2018, 24, 77–90. [Google Scholar] [CrossRef]
  33. Li, S.Y.; Fung, F.K.; Fu, Z.J.; Wong, D.; Chan, H.H.; Lo, A.C. Anti-inflammatory effects of lutein in retinal ischemic/hypoxic injury: In vivo and in vitro studies. Investig. Ophthalmol. Vis. Sci. 2012, 53, 5976–5984. [Google Scholar] [CrossRef] [Green Version]
  34. Renzi, L.M.; Dengler, M.J.; Puente, A.; Miller, L.S.; Hammond, B.R., Jr. Relationships between macular pigment optical density and cognitive function in unimpaired and mildly cognitively impaired older adults. Neurobiol. Aging 2014, 35, 1695–1699. [Google Scholar] [CrossRef]
  35. Sujak, A.; Gabrielska, J.; Grudziński, W.; Borc, R.; Mazurek, P.; Gruszecki, W.I. Lutein and Zeaxanthin as Protectors of Lipid Membranes against Oxidative Damage: The Structural Aspects. Arch. Biochem. Biophys. 1999, 371, 301–307. [Google Scholar] [CrossRef]
  36. Erdman, J.W., Jr.; Smith, J.W.; Kuchan, M.J.; Mohn, E.S.; Johnson, E.J.; Rubakhin, S.S.; Wang, L.; Sweedler, J.V.; Neuringer, M. Lutein and Brain Function. Foods 2015, 4, 547–564. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Targher, G.; Marra, F.; Marchesini, G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: Causal effect or epiphenomenon? Diabetologia 2008, 51, 1947–1953. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Kim, J.E.; Clark, R.M.; Park, Y.; Lee, J.; Fernandez, M.L. Lutein decreases oxidative stress and inflammation in liver and eyes of guinea pigs fed a hypercholesterolemic diet. Nutr. Res. Pract. 2012, 6, 113–119. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. Lee, Y.; Hu, S.; Park, Y.K.; Lee, J.Y. Health Benefits of Carotenoids: A Role of Carotenoids in the Prevention of Non-Alcoholic Fatty Liver Disease. Prev. Nutr. Food Sci. 2019, 24, 103–113. [Google Scholar] [CrossRef] [PubMed]
  40. Kjaergaard, K.; Mikkelsen, A.C.D.; Wernberg, C.W.; Gronkjaer, L.L.; Eriksen, P.L.; Damholdt, M.F.; Mookerjee, R.P.; Vilstrup, H.; Lauridsen, M.M.; Thomsen, K.L. Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease-Current Knowledge, Mechanisms and Perspectives. J. Clin. Med. 2021, 10, 673. [Google Scholar] [CrossRef]
Figure 1. Path diagram of mediation model. “a1–a4”: the effect of per category of dietary or total L and Z intake on the US FLI; “b”: the effect of US FLI on cognitive function (CERAD W-L or the Animal Fluency test or DSST); “c’1c’4”: the direct effect of per category of dietary or total L and Z intake on cognitive function (CERAD W-L or the Animal Fluency test or DSST). The first category of dietary or total L and Z intake is the reference group. Original to this manuscript.
Figure 1. Path diagram of mediation model. “a1–a4”: the effect of per category of dietary or total L and Z intake on the US FLI; “b”: the effect of US FLI on cognitive function (CERAD W-L or the Animal Fluency test or DSST); “c’1c’4”: the direct effect of per category of dietary or total L and Z intake on cognitive function (CERAD W-L or the Animal Fluency test or DSST). The first category of dietary or total L and Z intake is the reference group. Original to this manuscript.
Nutrients 14 00578 g001
Table 1. Characteristics of NHANES participants, 2011–2014.
Table 1. Characteristics of NHANES participants, 2011–2014.
CharacteristicAll NHANES
Participants Aged ≥ 60 Years (n = 3632)
NHANES
Participants Included in this Analysis (n = 604)
Total (Weighted n)59,784,35529,397,912
NHANES cycle, n % (SE)
2011–201249.06 (0.03)51.11 (0.04)
2013–201450.94 (0.03)48.89 (0.04)
Age (years), mean ± SE69.40 ± 0.2868.11 ± 0.32
Sex, n% (SE)
Male44.52 (0.01)49.88 (0.02)
Female55.48 (0.01)50.12 (0.02)
Race/ethnicity, n% (SE)
Mexican American 3.82 (0.01)2.75 (0.01)
Other Hispanic3.70 (0.01)2.61 (0.01)
Non-Hispanic white77.45 (0.02)86.85 (0.02)
Non-Hispanic Black8.99 (0.01)5.39 (0.01)
Other/multiracial6.05 (0.01)2.40 (0.01)
Education >12 years, n% (SE)80.87 (0.02)87.76 (0.02)
GGT (IU/L), mean ± SE26.39 (1.07)24.90 (1.16)
Fasting insulin (pmol /L), mean ± SE75.95 ± 2.8175.40 ± 4.08
Waist circumference (cm), mean ± SE102.76 ± 0.79102.96 ± 0.95
Fasting glucose (mg/ dL), mean ± SE112.77 ± 1.55111.74 ± 1.80
Total energy intake (kcal), mean ± SE1842.587 ± 27.571937.78 ± 34.93
Dietary L and Z intake (mg/day), mean ± SE2091.91 ± 328.522592.69 ± 593.34
Total L and Z intake (mg/day), mean ± SE2344.65 ± 353.852841.43 ± 644.91
CERAD W-L: Total Score (3 Recall trials), mean ± SE19.82 ± 0.2720.38 ± 0.27
Animal Fluency Test: Total Score, mean ± SE17.96 ± 0.2318.93 ± 0.27
DSST: Total Score, mean ± SE51.71 ± 0.7756.27 ± 0.92
Abbreviations: GGT: gamma glutamyltransferase; CERAD W-L: Consortium to Establish a Registry for Alzheimer’s disease Word Learning subset; DSST: the Digit Symbol Substitution Test.
Table 2. Mean (SD) scores on cognitive tests and US FLI, by quartile of L and Z intake (diet and total intake).
Table 2. Mean (SD) scores on cognitive tests and US FLI, by quartile of L and Z intake (diet and total intake).
GroupQ1 (n = 152)
Weighted (n) = 6, 469, 326
Q2 (n = 149)
Weighted (n) = 6, 899, 307
Q3 (n = 152)
Weighted (n) = 7, 924, 034
Q4 (n = 151)
Weighted (n) = 8, 105, 244
p-Value for Difference
Dietary L and Z intake
US FLI31.43 (21.81)34.46 (23.39)29.19 (22.01)23.48 (19.71)<0.001
CERAD W-L:
Total Score
18.70 (4.36)19.46 (4.39)19.60 (4.61)20.39 (4.40)<0.05
Animal Fluency Test: Total Score 16.74 (5.54)17.56 (5.33)18.07 (5.31)18.81 (5.55)<0.05
DSST: Total Score46.36 (16.96)49.49 (17.43)52.11 (16.13)54.01 (16.14)<0.001
Z-score−0.19 (0.79)−0.05 (0.76)0.05 (0.79)0.19 (0.71)<0.001
Total L and Z intake
US FLI31.82 (22.88)34.14 (23.68)28.60 (20.99)23.95 (19.38)<0.001
CERAD W-L:
Total Score
18.56 (4.38)19.49 (4.42)19.75 (4.53)20.35 (4.40)<0.05
Animal Fluency Test: Total Score 16.46 (5.45)17.96 (5.99)18.09 (4.90)18.68 (5.29)<0.05
DSST: Total Score45.14 (17.08)49.84 (17.59)52.88 (16.11)54.11 (15.37)<0.001
Z-score−0.24 (0.79)−0.04 (0.78)0.09 (0.76)0.19 (0.70)<0.001
Continuous variables are expressed as means (standard error). p-values based on ANOVA for continuous variables, which accounted for National Health and Nutrition Examination Survey. Bold font indicates that the result is statistically significant.
Table 3. Associations of the US FLI and L and Z with cognitive function (β (95% CI)).
Table 3. Associations of the US FLI and L and Z with cognitive function (β (95% CI)).
CERAD W-L:
Total Score
Animal Fluency Test:
Total Score
DSST:
Total Score
Z-Score
Crude model
US FLI−0.02 (−0.05, 0.00)−0.03 (−0.05, −0.01)−0.10 (−0.20, −0.01)−0.004 (−0.01, −0.00)
Quartile of dietary L and Z
Q2 vs. Q10.98 (−0.54, 2.51)0.83 (−0.68, 2.34)4.36 (−1.55, 10.26)0.19 (−0.07, 0.45)
Q3 vs. Q11.22 (−0.10, 2.55)1.01 (−0.29, 2.31)5.34 (−0.40, 11.09)0.25 (0.02, 0.48)
Q4 vs. Q11.93 (0.41, 3.45)2.64 (0.81, 4.47)7.93 (2.27, 13.59)0.42 (0.18, 0.66)
Quartile of total L and Z
Q2 vs. Q10.71 (−0.44, 1.85)1.06 (-0.39, 2.50)5.03 (−1.26, 11.32)0.16 (−0.08, 0.40)
Q3 vs. Q11.54 (0.45, 1.85)1.85 (0.47, 3.22)7.87 (2.17, 13.57)0.36 (0.13, 0.60)
Q4 vs. Q11.88 (0.54, 3.22)2.54 (0.91, 4.18)8.93 (3.61, 14.25)0.42 (0.21, 0.63)
Adjusted model
US FLI−0.01 (−0.03, 0.01)−0.03 (−0.06, −0.01)−0.09 (−0.16, −001)−0.004 (−0.01, −0.00)
Quartile of dietary L and Z
Q2 vs. Q10.63 (−0.47, 1.72)0.66 (−0.53, 1.85)3.86 (−0.82, 8.55)0.14 (−0.06, 0.33)
Q3 vs. Q11.07 (−0.01, 2.15)0.72 (−0.49, 1.93)4.28 (−0.48, 9.03)0.21 (0.03, 0.38)
Q4 vs. Q11.32 (0.05, 2.59)2.15 (0.47, 3.84)4.71 (0.60, 8.82)0.29 (0.09, 0.49)
Quartile of total L and Z
Q2 vs. Q10.69 (−0.19, 1.57)1.09 (−0.25, 2.44)4.87 (0.38, 9.35)0.16 (−0.02, 0.34)
Q3 vs. Q11.42 (0.54, 2.31)1.47 (0.22, 2.72)6.13 (1.70, 10.57)0.31 (0.13, 0.49)
Q4 vs. Q11.37 (0.19, 2.54)2.10 (0.44, 3.76)5.71 (1.58, 9.83)0.30 (0.11, 0.49)
Adjusted model: age, sex, race, the survey year, the total energy intake, the education level. Abbreviations: Q2, the second quartile; Q3, the third quartile; Q4, the fourth quartile; CERAD W-L, the CERAD Word Learning subtest; DSST, the Digit Symbol Substitution Test. Bold font indicates that the result is statistically significant.
Table 4. β (p) of the US FLI according to the quartile of dietary or total intake of L and Z.
Table 4. β (p) of the US FLI according to the quartile of dietary or total intake of L and Z.
Q2 vs. Q1Q3 vs. Q1Q4 vs. Q1
Quartile of dietary L and Z intake
US FLI (Crude model)1.22 (0.77)−2.34 (0.61)−10.99 (<0.01)
US FLI (Adjusted model) 0.74 (0.86)−2.27 (0.61)−10.23 (<0.01)
Quartile of total L and Z intake
US FLI (Crude model)0.75 (0.85)−4.48 (0.32)−10.75 (0.02)
US FLI (Adjusted model) 0.43 (0.91)−4.22 (0.32)−9.84 (0.02)
Adjusted for age, race, sex, the survey year, the total energy intake, the education level. Bold font indicates that the result is statistically significant.
Table 5. Adjusted Model: Mediation Analysis of the relationship between quartile of dietary L and Z intake and cognitive function by the US FLI (β (95% CI)).
Table 5. Adjusted Model: Mediation Analysis of the relationship between quartile of dietary L and Z intake and cognitive function by the US FLI (β (95% CI)).
Relative Mediation AnalysisQ2 vs. Q1 1Q3 vs. Q1 1Q4 vs. Q1 1
CERAD W-L: Total Score
Direct Effect (c’n)0.63 (−0.53, 1.76)1.04 (−0.07, 2.17)1.21 (0.09, 2.37)
Indirect Effect (an × b)−0.01 (−0.16, 0.06)0.03 (−0.03, 0.19)0.11 (−0.03, 0.35)
PE (%)---
Animal Fluency Test: Total Score
Direct Effect (c’n)0.68 (−0.77, 2.07)0.65 (−0.76, 2.02)1.86 (0.31, 3.31)
Indirect Effect (an × b)−0.02 (−0.30, 0.18)0.07 (−0.10, 0.35)0.30 (0.07, 0.75)
PE (%)--13.89
DSST: Total Score
Direct Effect (c’n)3.93 (−0.11, 8.33)4.09 (0.20, 7.92)3.86 (−0.16, 7.97)
Indirect Effect (an × b)−0.06 (−0.66, 0.59)0.19 (−0.30, 0.98)0.84 (0.21, 1.95)
PE (%)--17.87
Z-score
Direct Effect (c’n)0.14 (−0.05, 0.33)0.20 (0.01, 0.38)0.25 (0.05, 0.44)
Indirect Effect (an × b)−0.01 (−0.03, 0.04)0.01 (−0.01, 0.04)0.04 (0.01, 0.09)
PE (%)--13.79
1 Adjusted model; age, sex, race, the survey year, the total energy intake, the education level. PE = relative indirect effect/ (relative direct effect + relative indirect effect). Statistically significant at no more than the 0.05 level. Bold font indicates that the result is statistically significant.
Table 6. Adjusted Model: Mediation analysis of the relationship between quartile of total L and Z intake (diet and supplement) and cognitive function by the US FLI (β (95% CI)).
Table 6. Adjusted Model: Mediation analysis of the relationship between quartile of total L and Z intake (diet and supplement) and cognitive function by the US FLI (β (95% CI)).
Relative Mediation AnalysisQ2 vs. Q1 1Q3 vs. Q1 1Q4 vs. Q1 1
CERAD W-L: Total Score
Direct Effect (c’n)0.70 (−0.40, 1.83)1.38 (0.27, 2.51)1.26 (0.19, 2.43)
Indirect Effect (an × b)−0.004 (−0.14, 0.08)0.05 (−0.02, 0.22)0.11 (−0.03, 0.35)
PE (%)---
Animal Fluency Test: Total Score
Direct Effect (c’n)1.11 (−0.41, 2.53)1.34 (0.05, 2.72)1.80 (0.33, 3.19)
Indirect Effect (an × b)−0.01 (−0.30, 0.20)0.13 (−0.04, 0.47)0.30 (0.07, 0.76)
PE (%)--14.29
DSST: Total Score
Direct Effect (c’n)4.90 (0.71, 9.34)5.80 (1.66, 9.84)4.92 (0.61, 9.18)
Indirect Effect (an × b)−0.03 (−0.60, 0.61)0.34 (−0.11, 1.18)0.78 (0.18, 1.81)
PE (%)--13.68
Z-score
Direct Effect (c’n)0.16 (−0.03, 0.36)0.30 (0.12, 0.49)0.26 (0.07, 0.45)
Indirect Effect (an × b)−0.001 (−0.03, 0.02)0.01 (−0.004, 0.05)0.03 (0.01, 0.09)
PE (%)--10.34
1 Adjusted model; age, sex, race, the survey year, the total energy intake, the education level. PE = relative indirect effect/ (relative direct effect + relative indirect effect). Statistically significant at no more than the 0.05 level. Bold font indicates that the result is statistically significant.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Chen, C.; Lu, Z.; Zhang, D.; Li, S. The Mediation Role of the Risk of Non-Alcoholic Fatty Liver Disease in Relationship between Lutein and Zeaxanthin and Cognitive Functions among Older Adults in the United States. Nutrients 2022, 14, 578. https://doi.org/10.3390/nu14030578

AMA Style

Chen C, Lu Z, Zhang D, Li S. The Mediation Role of the Risk of Non-Alcoholic Fatty Liver Disease in Relationship between Lutein and Zeaxanthin and Cognitive Functions among Older Adults in the United States. Nutrients. 2022; 14(3):578. https://doi.org/10.3390/nu14030578

Chicago/Turabian Style

Chen, Chen, Zhonghai Lu, Dongfeng Zhang, and Suyun Li. 2022. "The Mediation Role of the Risk of Non-Alcoholic Fatty Liver Disease in Relationship between Lutein and Zeaxanthin and Cognitive Functions among Older Adults in the United States" Nutrients 14, no. 3: 578. https://doi.org/10.3390/nu14030578

APA Style

Chen, C., Lu, Z., Zhang, D., & Li, S. (2022). The Mediation Role of the Risk of Non-Alcoholic Fatty Liver Disease in Relationship between Lutein and Zeaxanthin and Cognitive Functions among Older Adults in the United States. Nutrients, 14(3), 578. https://doi.org/10.3390/nu14030578

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop